Skip to main content

Journals in Oncology

Focusing on tumor biology, diagnostics, and targeted therapies, this portfolio supports oncologists, researchers, and clinicians. It features innovations that improve cancer detection, personalized treatments, and survivorship care.

  • Mutation Research: Reviews in Mutation Research

    • ISSN: 1383-5742
    The subject areas of Mutation Research - Reviews in Mutation Research (MRR) encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus, this section will cover:Advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concernGenetic toxicology and environmental mutagenesis (including the factors that modulate the genetic activity of environmental agents) will continue to be prominent topics in this section.MRR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM)
  • Current Problems in Cancer

    • ISSN: 0147-0272
    Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in translational and clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Pre-clinical studies are discouraged. The journal's format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.Original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation can be submitted to the journal's open access companion title, Current Problems in Cancer: Case Reports.(CPCCR). Any case reports submitted to Current Problems in Cancer (CPC) will be considered for publication in either CPC or CPCCR.
  • Human Pathology

    • ISSN: 0046-8177
    Human Pathology is designed to bring information of clinicopathologic significance to human disease to the laboratory and clinical physician. It presents information drawn from morphologic and clinical laboratory studies with direct relevance to the understanding of human diseases. Papers published concern morphologic and clinicopathologic observations, reviews of diseases, analyses of problems in pathology, significant collections of case material and advances in concepts or techniques of value in the analysis and diagnosis of disease. Theoretical and experimental pathology and molecular biology pertinent to human disease are included. This critical journal is well illustrated with exceptional reproductions of photomicrographs and microscopic anatomy.Case reports should be submitted to our open access companion title, Human Pathology: Case Reports.
  • Cancer Epidemiology

    • ISSN: 1877-7821
    Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).
  • European Journal of Surgical Oncology

    • ISSN: 0748-7983
    Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery.  The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.  The Editors welcome submissions on clinical research and all other aspects of surgical oncology which advance the care of patients with cancer, including surgical quality control, epidemiology, preventative aspects of surgical oncology, as well as translational research relevant to surgical oncology practice.We offer many author benefits including Your Paper, Your Way (YPYW). YPYW is an easier submission process, focusing on the quality of the science in the initial stages of submission and only requiring elements needed for eventual production at the revision stage. Please refer to the Guide for Authors for further information.
  • Practical Radiation Oncology

    • ISSN: 1879-8500
    An official journal of the American Society for Radiation Oncology (ASTRO)The overarching mission of Practical Radiation Oncology is to improve the quality of radiation oncology practice. PRO's purpose is to document the state of current practice, providing background for those in training and continuing education for practitioners, through discussion and illustration of new techniques, evaluation of current practices, and publication of case reports. PRO strives to provide its readers content that emphasizes knowledge "with a purpose." The content of PRO includes:Original articles focusing on patient safety, quality measurement, or quality improvement initiativesOriginal articles focusing on imaging, contouring, target delineation, simulation, treatment planning, immobilization, organ motion, and other practical issuesASTRO guidelines, position papers, and consensus statementsEssays that highlight enriching personal experiences in caring for cancer patients and their families PRO is the sister publication to the International Journal of Radiation Oncology, Biology, Physics and Advances in Radiation Oncology. Learn more about which types of papers the journals typically accept.DisclaimerThe views expressed in Practical Radiation Oncology (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libellous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.
  • American Journal of Preventive Medicine

    • ISSN: 0749-3797
    The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.
  • Clinical Genitourinary Cancer

    • ISSN: 1558-7673
    Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
  • Magnetic Resonance Imaging

    • ISSN: 0730-725X
    An International Journal of Basic Research and Clinical ApplicationsMagnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
  • Journal of Cancer Policy

    • ISSN: 2213-5383
    In affiliation with European Cancer Organisation Journal of Cancer Policy invites all readers to join the dedicated Twitter channel for the journal: https://twitter.com/... Journal of Cancer Policy is an international journal which publishes research and reviews on global cancer policy. The journal encompasses all aspects of cancer policy from prevention and public health through all modalities of control and cure, palliative care and survivorship including:* Cancer systems and services research * Cancer economics and value-based care * Inequalities in access and outcomes of cancer care * Development and regulatory issues related to cancer drugs, radiotherapy and surgical technologies * Priorities for cancer policy development in low, middle and high income countries * Innovative strategies for prevention, screening and diagnosis of cancer * Development of cancer research and education infrastructure * Social determinants of cancer * The role of trade, globalisation and the law in cancer control * The role of the media and patient advocacy in cancer policy * Policy and social science research germane to cancer * Patient advocacy and information researchThe Journal of Cancer Policy will consider original research, reviews, short communications and reports, and correspondence for publication.
  • DNA Repair

    • ISSN: 1568-7864
    DNA Repair (DNAREP) is a journal focusing on DNA repair and cellular responses to DNA damage. DNA Repair publishes articles on genetic, cellular, biochemical, structural and molecular aspects of DNA repair. The journal welcomes articles describing databases, methods and new technologies supporting research on DNA repair and responses to DNA damage. Letters to the Editor, hot topics and classics in DNA repair, historical reflections, book reviews and meeting reports will also be considered for publication.The journal publishes topics directly pertaining to DNA damage and repair, which include:ApoptosisBio... responses to genomic insultCell cycle regulationCell fate decisionsEpigenetics and chromatinGenomics/bi... diseases: aging, cancer, and neurological dysfunctionImmune responsesMutagenesis & signature mutationsStructural biology and computational modeling
  • The American Journal of Pathology

    • ISSN: 0002-9440
    The American Journal of Pathology (AJP), the official journal of the American Society for Investigative Pathology (ASIP), seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches. Case reports typically do not meet the criteria for inclusion.
  • Journal of Thoracic Oncology

    • ISSN: 1556-0864
    Official Journal of the International Association for the Study of Lung CancerAbout the JournalJournal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance.Authors are also welcome to submit to the journal's open access companion title, JTO Clinical and Research Reports, which welcomes a range of manuscripts from subset analyses of published trials to high-quality case reports.
  • European Journal of Oncology Nursing

    • ISSN: 1462-3889
    The European Journal of Oncology Nursing is an international journal which publishes research of direct relevance to patient care, nurse education, management and policy development. EJON is proud to be the official journal of the European Oncology Nursing Society.The journal publishes the following types of papers: • Original research articles • Review articles
  • Transplantation and Cellular Therapy

    • ISSN: 2666-6367
    Transplantation and Cellular Therapy, the official publication of the American Society for Transplantation and Cellular Therapy, is dedicated to the comprehensive development and advancement of the interdisciplinary field of hematopoietic cell transplantation (HCT) and cellular therapies. The Journal emphasizes excellence in clinical care and treatment outcomes through the promotion of standards, best practices, and evidence-based approaches in HCT and cellular therapy.The Journal focuses on current technology, groundbreaking research, and clinical applications in HCT and related cellular therapies. Committed to the rapid dissemination of basic, translational, and clinical research, Transplantation and Cellular Therapy publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor to advance scientific knowledge and inform both the medical community and the broader public.For further information and the most up to date journal policies, please review our Guide for Authors.
  • Clinical Colorectal Cancer

    • ISSN: 1533-0028
    Clinical Colorectal Cancer is devoted to manuscripts that focus on early detection/screening, diagnosis, prevention, and treatment of colorectal cancer and other GI cancers, including pancreatic, liver, gastric/gastroesopha... biliary, and other gastrointestinal cancers. The major emphasis is on recent scientific developments and original peer-reviewed manuscripts. Specific areas of interest include original reports on clinical research and/or translational research and translational correlative science that is directly related to clinical trials, in all (multidisciplinary) therapeutic fields that relate to colorectal cancer and other GI cancers.Further areas of interest include original research on drug sensitivity and resistance to cytotoxic agents, targeted therapies, immunotherapies, and other novel therapeutic approaches; pathology, (validated) predictive markers, and prognostic indicators; chemoprevention strategies; and integration of various therapeutic and multidisciplinary approaches. A much lower priority will be given to meta-analyses, pooled analyses, and real-world analyses unless the knowledge gained from such reports is significant and can be applied to clinical practice. In addition, unsolicited reviews are not encouraged unless there has been a discussion with the editor or deputy editors as the journal wants to ensure that reviews will provide real added value and true gain of knowledge.
  • Bone

    • ISSN: 8756-3282
    BONE is an interdisciplinary forum for the rapid publication of original articles and reviews on basic, translational, and clinical aspects of bone and mineral metabolism, including rare bone diseases. The Journal also encourages submissions related to interactions of bone with other organ systems, including cartilage, tendon and other connective tissues, endocrine, muscle, fat, neural, vascular, gastrointestinal, hematopoietic, and immune systems. Particular attention is placed on the application of artificial intelligence and experimental studies to clinical practice.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy.BONE and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.Original research articles and case reports can also be submitted to BONE's Gold Open Access companion title, Bone Reports.
  • Medical Dosimetry

    • ISSN: 0958-3947
    Official Journal of the American Association of Medical DosimetristsMedical Dosimetry, the official journal of the American Association of Medical Dosimetrists, is the key source of information on new developments for the medical dosimetrist. Practical and comprehensive in coverage, the journal features original contributions and review articles by medical dosimetrists, oncologists, physicists, and radiation therapy technologists on clinical applications and techniques of external beam, interstitial, intracavitary and intraluminal irradiation in cancer management. Articles dealing primarily with physics will be reviewed by a specially appointed team of experts in the field.
  • Radiotherapy & Oncology

    • ISSN: 0167-8140
    Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation Oncology.Radiotherap... and Oncology, also known as the Green journal, aims at driving innovation in radiation oncology. It publishes high impact articles describing original research as well as review articles. It covers all areas of interest relating to clinical radiotherapy and oncology, medical physics, radiation biology, as well as other areas relevant to the radiation oncology community such as education, health policy, environmental and societal sustainability or health economics. The journal has a particular interest in prospective clinical trials or large population-based database analyses. It also looks to publish works related to: clinical radiotherapy and brachytherapy, combined modality treatment (for example with chemotherapy, surgery and immunology), particle therapy, translational and experimental radiotherapy and radiation biology, medical physics, imaging, dosimetry, and radiation therapy planning, data science and artificial intelligence research relevant to radiotherapy.ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.
  • European Urology Oncology

    • ISSN: 2588-9311
    Official Journal of the European Association of Urology European Urology Oncology is a companion title to European Urology , European Urology Open Science and European Urology Focus , and is the first official publication of the EAU fully devoted to the study of genitourinary malignancies.The journal aims to deliver high quality research while implementing a multi-disciplinary approach to incorporate Urology, Medical Oncology, Radiation Therapy, Imaging, Pathology and Basic Research with the ultimate goal of advancing research in urological oncology.European Urology Oncology includes original articles, opinion piece editorials and invited reviews covering clinical, basic and translational research and is published six times a year in electronic format. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.
  • Journal of Radiology Nursing

    • ISSN: 1546-0843
    Official journal of the Association for Radiologic & Imaging Nursing (ARIN)The Journal of Radiology Nursing promotes the highest quality patient care in the diagnostic and therapeutic imaging environments. The content is intended to show radiology nurses how to practice with compassion, competence, and commitment, not only to patients but also to the profession of nursing as a whole. The journal's goals mirror those of the Association for Radiologic & Imaging Nursing: to provide, promote, maintain, and continuously improve patient care through education, standards, professional growth, and collaboration with other health care providers.
  • Medical Image Analysis

    • ISSN: 1361-8415
    An official journal of the MICCAI SocietyMedical Image Analysis provides a forum for the dissemination of new research results in the field of medical and biological image analysis, with special emphasis on efforts related to the applications of computer vision, virtual reality and robotics to biomedical imaging problems. The journal publishes the highest quality, original papers that contribute to the basic science of processing, analysing and utilizing medical and biological images for these purposes. The journal is interested in approaches that utilize biomedical image datasets at all spatial scales, ranging from molecular/cellular imaging to tissue/organ imaging. While not limited to these alone, the typical biomedical image datasets of interest include those acquired from:Magnetic resonanceUltrasoundC... tomographyNuclear medicineX-rayOptical and Confocal MicroscopyVideo and range data imagesThe types of papers accepted include those that cover the development and implementation of algorithms and strategies based on the use of various models (geometrical, statistical, physical, functional, etc.) to solve the following types of problems, using biomedical image datasets: representation of pictorial data, visualization, feature extraction, segmentation, inter-study and inter-subject registration, longitudinal / temporal studies, image-guided surgery and intervention, texture, shape and motion measurements, spectral analysis, digital anatomical atlases, statistical shape analysis, computational anatomy (modelling normal anatomy and its variations), computational physiology (modelling organs and living systems for image analysis, simulation and training), virtual and augmented reality for therapy planning and guidance, telemedicine with medical images, telepresence in medicine, telesurgery and image-guided medical robots, etc.
  • Critical Reviews in Oncology/Hematology

    • ISSN: 1040-8428
    Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world.The journal considers articles on the following themes:Basic Experimental OncologyCareer Development and Education in OncologyClinical ResearchHematologyIm... Pathology, Genomics and omics, and Liquid BiopsyPalliative SupportPediatric OncologyRadiotherapy... Ethics, and Health PolicySolid TumorsStatistics, Meta-analysis, and Clinical Trial DesignSurgeryCritica... Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy (ISLB).All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.
  • Seminars in Oncology Nursing

    • ISSN: 0749-2081
    Seminars in Oncology Nursing (SON) is a unique, international peer-reviewed journal, published six times a year. It features special issues that offer a multi-faceted overview of a contemporary cancer topic, relevant to patient care, nursing education, management, and/or policy development. Each special issue is led by Guest Editors who solicit articles from invited expert authors. In addition to solicited articles, the Editor-in-Chief welcomes the submission of unsolicited original research and review articles. SON publishes on all aspects of cancer nursing, whether in the field of research, practice, or education.
  • Annals of Oncology

    • ISSN: 0923-7534
    An official Journal of the European Society for Medical Oncology and the official journal of the Japanese Society of Medical OncologyAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.Wi... a large international editorial board of experts who are leaders in their fields, Annals of Oncology aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.
  • International Journal of Radiation Oncology, Biology, Physics

    • ISSN: 0360-3016
    An official journal of the American Society for Radiation OncologyInternationa... Journal of Radiation Oncology - Biology - Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.The Red Journal's related publications are Practical Radiation Oncology and Advances in Radiation Oncology. Learn more about which types of papers these journals typically accept.Disclaimer No responsibility is assumed by the Publisher or the American Society for Radiation Oncology for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual property or privacy rights, products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.The views expressed in The Red Journal (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libelous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.
  • Brachytherapy

    • ISSN: 1538-4721
    An International Multidisciplinary Journal Official Journal of the American Brachytherapy SocietyBrachytherapy is an international and multidisciplinary journal that publishes original peer-reviewed articles and selected reviews on the techniques and clinical applications of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include medical physics, medical oncology, and radiation oncology and radiology. Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited. Letters to the Editor-in-Chief are encouraged.
  • Leukemia Research

    • ISSN: 0145-2126
    Official journal of the Myelodysplastic Syndromes Foundation.Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.You are also welcome to submit to Leukemia Research's open access companion title, Leukemia Research Reports.
  • Experimental Hematology

    • ISSN: 0301-472X
    Journal for Hematology, Stem Cell Biology and TransplantationOffic... publication of the ISEH - International Society for Experimental HematologyExperiment... Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation. The goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment.The journal publishes topics including:Relevant developmental and aging processesStem cell biologyAnalyses of intrinsic and extrinsic regulatory mechanismsIn vitro behavior of primary cellsClonal trackingMolecular and omics analysesMetabolismEp... approachesStudies in model organismsNovel clinical observationsTranspla... biology and new therapeutic avenuesExperimental Hematology publishes two types of articles: Reviews and Perspectives and original findings sub-classified either as Brief Communications of significant singular results and Research Articles presenting the results of more developed studies.Experimental Hematology publishes Special Issues dedicated to important topics in the field. To view our Special Issues and article collections, click here.
  • The Journal of Nutritional Biochemistry

    • ISSN: 0955-2863
    Devoted to advancements in nutritional sciences, The Journal of Nutritional Biochemistry presents experimental nutrition and clinical nutrition research as it interfaces with biochemistry, molecular biology, physiology, and toxicology. The scope of the journal includes the broad area of in vivo and in vitro studies of mechanistic aspects of nutritional sciences. Preferred manuscripts include studies, which focus on nutrients and/or bioactive compounds with nutritional value derived from diets/whole foods as it relates to: biochemistry, molecular biology, toxicology, immunology or physiology and human health and diseases.Rigorous reviews by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research articles, The Journal of Nutritional Biochemistry also periodically publishes emerging issues, experimental methods, and other types of articles such as but not limited to policy statements.Contact InformationReto Asmis, Ph.D, Editor-in-Chief The Journal of Nutritional Biochemistry Professor, Internal Medicine, Section on Molecular Medicine Wake Forest School of Medicine Medical Center Boulevard, Winston-Salem, NC 27157 E-mail address: [email protected]...
  • Journal of Geriatric Oncology

    • ISSN: 1879-4068
    The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-C... Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
  • European Journal of Cancer

    • ISSN: 0959-8049
    Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care.  Within its digital oncology scope, the journal welcomes high-quality studies on artificial intelligence, machine learning, computational imaging and pathology, digital biomarkers, real-world data, electronic health record-based research, digital therapeutics, clinical decision support, large language models and other digital health applications relevant to cancer prevention, diagnosis, treatment, survivorship and patient care. The journal prioritises digital and AI studies that are clinically grounded, methodologically robust, transparently reported, appropriately validated, and that consider generalisability, reproducibility, patient safety, privacy, equity and potential sources of bias.  The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).
  • The Lancet

    • ISSN: 0140-6736
    The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
  • Cytokine & Growth Factor Reviews

    • ISSN: 1359-6101
    Cytokine & Growth Factor Reviews publishes focused research reviews (state-of-the-art reviews, correspondence, perspectives, meeting reviews) devoted to important advances in fields of cytokine and growth factor research. Major emphasis will be placed on reviews that detail molecular mechanistic analysis of diverse areas of biomedical research, including cytokine regulation of immune responses, innate immunity, viral pathogenesis, inflammatory disorders including neuroinflammation, growth regulation in cancer, cytokines in the tumor microenvironment and cytokine-guided immunotherapeutic strategies. Priority will be given to those reviews with a focused expert perspective, provided by scientific leaders in their respective areas of research. Broad literature reviews with an overview perspective rather than a research focus should consider other Elsevier venues.
  • The Lancet Oncology

    • ISSN: 1470-2045
    The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to clinical cancer specialties worldwide. Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology.
  • Seminars in Oncology

    • ISSN: 0093-7754
    Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
  • Oral Oncology

    • ISSN: 1368-8375
    A Journal Related to Head & Neck OncologyOral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngolog... plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes):• Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. • Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
  • Seminars in Radiation Oncology

    • ISSN: 1053-4296
    Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
  • Surgical Oncology

    • ISSN: 0960-7404
    A journal of cancer management & researchSurgical Oncology (SO) is an internationally peer reviewed journal publishing original research both clinical and translational, comprehensive reviews, multimedia articles, and meta-analyses that contribute to the advancement of knowledge in surgical oncology. Occasionally, SO publishes exceptional editorials and commentaries as they relate to selected papers. SO's articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation/outcomes.
  • Gynecologic Oncology

    • ISSN: 0090-8258
    Gynecologic Oncology is the The Society of Gynecologic Oncology's (SGO) official peer-reviewed journal. It is dedicated to publishing high-quality science and educational content that addresses the full continuum of gynecologic cancer care.The Journal will publish innovative research that provides actionable insights related to prevention, detection, treatment and survivorship in gynecologic cancers. The focus of these publications will generally be clinically relevant and includes clinical trials, radiation and surgical innovation, health outcomes and diversity research, epidemiology, and patient-centered quality of life research. Translational research with promise to affect clinical treatment innovation will receive priority.With an international editorial board of experts and key opinion leaders, the Journal will support multiple stakeholders as they aim to solve complex gynecologic cancer problems. Providing essential reading for all stakeholders we will publish original research, invited reviews, editorials, perspectives, and correspondence. Importantly, as the official journal of the SGO, the Journal will publish communications from the SGO including abstracts, practice statements and guidelines.
  • Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis

    • ISSN: 1386-1964
    A section of Mutation ResearchMutation Research (MR) provides a platform for publishing all aspects of DNA mutations and epimutations, from basic evolutionary aspects to translational applications in genetic and epigenetic diagnostics and therapy. Mutations are defined as all possible alterations in DNA sequence and sequence organization, from point mutations to genome structural variation, chromosomal aberrations and aneuploidy. Epimutations are defined as alterations in the epigenome, i.e., changes in DNA methylation, histone modification and small regulatory RNAs.MR publishes articles in the following areas:Of special interest are basic mechanisms through which DNA damage and mutations impact development and differentiation, stem cell biology and cell fate in general, including various forms of cell death and cellular senescence.The study of genome instability in human molecular epidemiology and in relation to complex phenotypes, such as human disease, is considered a growing area of importance.Mechanism... of (epi)mutation induction, for example, during DNA repair, replication or recombination; novel methods of (epi)mutation detection, with a focus on ultra-high-throughpu... sequencing.Landscape of somatic mutations and epimutations in cancer and aging.Role of de novo mutations in human disease and aging; mutations in population genomics.Interaction... between mutations and epimutations.The role of epimutations in chromatin structure and function.Mitochondri... DNA mutations and their consequences in terms of human disease and aging.Novel ways to generate mutations and epimutations in cell lines and animal models.MR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM) Mutation Research - Reviews (MRR)
  • The Journal of Heart and Lung Transplantation

    • ISSN: 1053-2498
    The Journal of Heart and Lung Transplantation (JHLT), the official publication of the International Society for Heart and Lung Transplantation, brings readers cutting-edge clinical, basic, and translational science in the fields of advanced heart and lung disease, cardio-pulmonary transplantation, mechanical and biological support of the failing heart, pulmonary vascular disease (pulmonary arterial hypertension and CTEPH), extracorporeal support of donor organs, and cell replacement therapy.
  • Cancer Letters

    • ISSN: 0304-3835
    Cancer Letters is an international journal providing a forum for original and pertinent contributions in cancer research.Cancer Letters considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.
  • Journal of Pain and Symptom Management

    • ISSN: 0885-3924
    Advancing Palliative Care, Hospice, and Symptom ResearchOfficial Journal of the American Academy of Hospice and Palliative Medicine and the National Alliance for Care at Home The Journal of Pain and Symptom Management is an internationally respected, peer-reviewed journal and serves an interdisciplinary audience of professionals by providing a forum for the publication of the latest clinical research and best practices related to the relief of illness burden among patients afflicted with serious or life-threatening illness.The Journal has strongly supported both quantitative and qualitative research underpinning the evolving discipline of palliative care, including clinical trials of pain or symptom control therapies, epidemiology of phenomena related to life-threatening disease and end-of-life care, instrument development to enhance clinical assessment and facilitate investigation, and health services studies evaluating the outcomes of diverse therapeutic models. It also offers extensive coverage of clinical practice issues, publishing both systematic and narrative reviews, case series and case reports, and both special articles and columns that present important updates on topics as varied as the international diversity of palliative medicine, the economics of palliative care, and bioethics in end-of-life care.
  • The Journal of Heart and Lung Transplantation

    • ISSN: 1053-2498
    The Journal of Heart and Lung Transplantation (JHLT), the official publication of the International Society for Heart and Lung Transplantation, brings readers cutting-edge clinical, basic, and translational science in the fields of advanced heart and lung disease, cardio-pulmonary transplantation, mechanical and biological support of the failing heart, pulmonary vascular disease (pulmonary arterial hypertension and CTEPH), extracorporeal support of donor organs, and cell replacement therapy.
  • Cytokine & Growth Factor Reviews

    • ISSN: 1359-6101
    Cytokine & Growth Factor Reviews publishes focused research reviews (state-of-the-art reviews, correspondence, perspectives, meeting reviews) devoted to important advances in fields of cytokine and growth factor research. Major emphasis will be placed on reviews that detail molecular mechanistic analysis of diverse areas of biomedical research, including cytokine regulation of immune responses, innate immunity, viral pathogenesis, inflammatory disorders including neuroinflammation, growth regulation in cancer, cytokines in the tumor microenvironment and cytokine-guided immunotherapeutic strategies. Priority will be given to those reviews with a focused expert perspective, provided by scientific leaders in their respective areas of research. Broad literature reviews with an overview perspective rather than a research focus should consider other Elsevier venues.
  • Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis

    • ISSN: 1386-1964
    A section of Mutation ResearchMutation Research (MR) provides a platform for publishing all aspects of DNA mutations and epimutations, from basic evolutionary aspects to translational applications in genetic and epigenetic diagnostics and therapy. Mutations are defined as all possible alterations in DNA sequence and sequence organization, from point mutations to genome structural variation, chromosomal aberrations and aneuploidy. Epimutations are defined as alterations in the epigenome, i.e., changes in DNA methylation, histone modification and small regulatory RNAs.MR publishes articles in the following areas:Of special interest are basic mechanisms through which DNA damage and mutations impact development and differentiation, stem cell biology and cell fate in general, including various forms of cell death and cellular senescence.The study of genome instability in human molecular epidemiology and in relation to complex phenotypes, such as human disease, is considered a growing area of importance.Mechanism... of (epi)mutation induction, for example, during DNA repair, replication or recombination; novel methods of (epi)mutation detection, with a focus on ultra-high-throughpu... sequencing.Landscape of somatic mutations and epimutations in cancer and aging.Role of de novo mutations in human disease and aging; mutations in population genomics.Interaction... between mutations and epimutations.The role of epimutations in chromatin structure and function.Mitochondri... DNA mutations and their consequences in terms of human disease and aging.Novel ways to generate mutations and epimutations in cell lines and animal models.MR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM) Mutation Research - Reviews (MRR)
  • Journal of Radiology Nursing

    • ISSN: 1546-0843
    Official journal of the Association for Radiologic & Imaging Nursing (ARIN)The Journal of Radiology Nursing promotes the highest quality patient care in the diagnostic and therapeutic imaging environments. The content is intended to show radiology nurses how to practice with compassion, competence, and commitment, not only to patients but also to the profession of nursing as a whole. The journal's goals mirror those of the Association for Radiologic & Imaging Nursing: to provide, promote, maintain, and continuously improve patient care through education, standards, professional growth, and collaboration with other health care providers.
  • Nutrition Research

    • ISSN: 0271-5317
    An International Publication for Nutrition to Advance Food and Life Science ResearchThe mission of Nutrition Research is to serve as the premier journal for the global communication of nutrition sciences research. Our primary goal is to publish research across the broad field of nutrition sciences that advances human health and promotes clinical applications through a comprehensive understanding of dietary patterns, foods, nutrients, and bioactive food components. This understanding includes exploring diet-related interactions with environmental exposures, human behavior, genetics, and underlying health status.Nutrition Research aims to contribute to the advancement of fundamental knowledge and facilitate research translation in support of public health. We achieve this by publishing nutrition sciences research that establishes mechanisms and demonstrates the efficacy or detriment of dietary exposures and interventions. We welcome studies conducted in humans, populations, and cellular and animal models, particularly those related to biomolecular nutrition, precision nutrition, (multi)omic workflows, nutrition interventions, randomized controlled trials, and novel methodological approaches and techniques that advance the nutrition sciences field. Furthermore, Nutrition Research is committed to promoting diversity, equity, inclusivity, and justice in the field through the dedicated efforts of its globally diverse editorial board. We also actively encourage the submission of research from all geographic regions and topics addressing health inequities and improvements in the health of vulnerable and/or underrepresented populations.Nutritio... Research publishes peer-reviewed research and articles related to all aspects of nutrition sciences that are relevant to the health of humans and populations. We welcome the following types of submissions:Original ResearchNarrative reviewsSystematic Reviews/Meta-Analyse... Trial Protocols in Human NutritionMethodologi... Advances in Nutrition ResearchShort CommunicationsEditor... and OpinionsDavid Kritchevsky Graduate Student AwardSince 2010 Nutrition Research has sponsored the David Kritchevsky Graduate Student Award with support provided by Elsevier. This prestigious award recognizes outstanding articles published in Nutrition Research by graduate and professional students. Annually, two awards of $1000 (USD) each are presented to these early-career scientists.